The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer
- 1 March 2015
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1852 (3) , 520-528
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81472638, 30921140312, 81171996, 81272289, 81200975)
- Young Outstanding Scholarship Foundation of Anhui Medical University
- Wujieping Medical Foundation (320.6750.13252)
This publication has 38 references indexed in Scilit:
- The Notch signaling pathway as a mediator of tumor survivalCarcinogenesis, 2013
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2013
- Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer DrugsCurrent Cancer Drug Targets, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Progress in Personalizing Chemotherapy for Bladder CancerAdvances in Urology, 2012
- Cellular senescence and cancer chemotherapy resistanceDrug Resistance Updates, 2012
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Adaptation to Oxidative Stress, Chemoresistance, and Cell SurvivalAntioxidants & Redox Signaling, 2009
- Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder CancerJournal of Clinical Oncology, 2005